いくつかの主要投資家は,アストラゼネカの株価を増加させ,その収益は高いと報告され,市場キャピタルは216.720億ドルです. Several major investors increased their stakes in AstraZeneca, which reported strong earnings and has a market cap of $216.72 billion.

複数の機関投資家が第1四半期にアストラゼネカPLCの保有額を増加させた. Several institutional investors boosted their holdings in AstraZeneca PLC during the first quarter. カンダアグア国立銀行,スミス・サリー・ファイナンス,シデル・アセット管理はそれぞれ11.6%,3.8%の株を増額し,それぞれ46,0303株を追加した. Canandaigua National Bank, Smith Salley Wealth Management, and Cidel Asset Management increased their shares by 11.6%, 3.8%, and added 46,033 shares respectively. アストラゼネカは,EPS1.24ドルで予想を上回る強力な収益を報告し,市場キャピタルは216.720億ドルです. AstraZeneca reported strong earnings, beating estimates with $1.24 EPS, and has a market cap of $216.72 billion. 株式は"モデレート・バイヤー"の評価で,平均価格は85.00ドルである. The stock has a "Moderate Buy" rating with an average price target of $85.00.